SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-038491
Filing Date
2020-06-23
Accepted
2020-06-23 16:44:21
Documents
1
Period of Report
2020-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3845
  Complete submission text file 0001209191-20-038491.txt   5178
Mailing Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878 240-558-0038
Viela Bio, Inc. (Issuer) CIK: 0001734517 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Nolet Chris (Reporting) CIK: 0001782814 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39067 | Film No.: 20982666